Sarah Huckabee Sanders has undergone a noticeable weight-loss transformation in recent years, which caused speculation as to ...

Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...

A new study suggests that almost half of people stopping GLP-1 weight-loss drugs may keep the weight off. However, many of these people continued other forms of treatment after stopping GLP-1 drugs.

The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with ...

A higher dose of Novo Nordisk’s GLP-1 injection Wegovy is coming to U.S. pharmacy shelves next month. The Danish drugmaker on Thursday announced the approval of a 7.2 mg dose ca ...

Stopping popular weight-loss injections like Ozempic or Mounjaro might not trigger the dramatic rebound many fear. A large real-world study of nearly 8,000 patients found that most people who ...

Wegovy HD's approval was granted within 54 days of filing, marking the fourth approval under the FDA Commissioner's National ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the personal care stocks, including Herbalife (NYSE:HLF ...